SEC Form 4 · accession 0001144204-15-069913
IMMUNE PHARMACEUTICALS INC · IMNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Gedeon Teper
Officer — CEO · Director · 10% Owner
Period of report
Dec 7, 2015
Accepted (ET)
Dec 8, 2015 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001208261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2015 | P | 65,400 | $0.7634 | A | 4,623,305 | D |
Table II — derivative securities
No Table II lines on this filing.